Radiothérapie des glioblastomes : de la radiobiologie à la chimiothérapie concomitante
Authors:
- J.-M. SimonJSJ.-M. Simon
- T. ToubianaTTT. Toubiana
- P. LangPLP. Lang
- S. TaillibertSTS. Taillibert
- J.-J. MazeronJMJ.-J. Mazeron
- 1 September 2005
- journal article
- review article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 9 (5) , 322-331
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma PatientsClinical Cancer Research, 2004
- A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancerLung Cancer, 2004
- Novel chemotherapeutic agents for the treatment of glioblastoma multiformeExpert Opinion on Investigational Drugs, 2003
- Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBritish Journal of Cancer, 2003
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- In vitro evaluation of temozolomide combined with X-irradiationAnti-Cancer Drugs, 1997
- Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomasRadiotherapy and Oncology, 1995
- Brachytherapy of Brain TumorsStereotactic and Functional Neurosurgery, 1992
- Intratumoral oxygen pressure in malignant brain tumorJournal of Neurosurgery, 1991